5Wheelden NM, Tayler DI, Anagnostou E, et al. Screening atrial fibrillation in primary care[J]. Heart, 1998,79:50-55
6Feinberg WM. Anticoagulation for prevention of stroke[J]. Neurology, 1998,51(3):20-22
7Muramatsu H, Shimura T. Incidence of cerebral thromboembolic infarction associated with paroxysmal and persistent or permanent atrial fibrillation[J].JACC, 2000, 35:103-104
8The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular at long risk of strike during treatment with aspiring: strike prevention in atrial fibrillation Ⅲ study[J]. JAMA, 1998,279:1273-1277
9EAFT Study Group. European atrial fibrillation trial: secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and a recent transient ischemic attack or minor ischemic stroke[J]. Lacent, 1993,342:1255-1262
10Ezekowize M D.Levine J A. Prevention stoke in patient with atrial fibrillation [J]. JAMA,1999,281(19):1830.
3Kannel WB, D' Agostino RB, Wilson PW, et al. Diabetes, fibrinogen, and risk of cardiovascular disease: the framingham experience [ J ]. Am Heart J, 1990,120 (3) :672 - 676.
4Johnson CE, Lira WK, Workman BS. People aged over 75 in atrial fibrillation on warfarin: the rate of major hemorrhage and stroke in more than 500 patient-years of follow-up [ J ]. J Am Geriatr Soc, 2005,53(4) :655 -659.
